CapsoVision, Inc. (CV)
Makes swallowable camera capsules that film inside the digestive system to detect disease.
$6.62+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+69.3%
The outlook
CV trades at $6.62 and sits near the lower end of its 52-week range. Analyst coverage shows an average price target around 51% above current levels, though the stock trades mixed relative to its moving averages. The overall sentiment leans neutral.
What’s behind the score
Price trendMixed vs its moving averages
52-week range27% of the way from its 52-week low to high
Price targetAvg target +51% vs current price
Market cap
$330.8M
52-wk high
$15.37
52-wk low
$3.43
50-day avg
$6.75
200-day avg
$6.58
Trailing P/E
—